Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6446]

Proof-of-concept study advances potential new way to deliver gene therapy

Proof-of-concept study advances potential new way to deliver gene therapy

Deep learning-based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

Deep learning-based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

On the trail of missing genes and cancer clues

On the trail of missing genes and cancer clues

Advanced nanoparticles provide new weapon to fight difficult cancers

Advanced nanoparticles provide new weapon to fight difficult cancers

US NIH report: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer

US NIH report: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

Results revealed from phase I clinical trial of the first drug to successfully inhibit the MYC gene, which drives many common cancers

Results revealed from phase I clinical trial of the first drug to successfully inhibit the MYC gene, which drives...

Response-adapted ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

Response-adapted ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B...

Targeting one type of immune cell with another slows cancer growth in preclinical studies

Targeting one type of immune cell with another slows cancer growth in preclinical studies

Scientists pinpoint druggable target in aggressive breast cancer

Scientists pinpoint druggable target in aggressive breast cancer

More from ecancer